People

Our headquarters is comprised of four highly skilled researchers specializing in the development and clinical evaluation of vaccines for both animal and human use, along with one administrative staff member.

Team

Hyun-Jin Shin, CEO

CELLENVAX Co.,Ltd , Korea

Univ. of Minnesota PhD
Northwestern Medical Center Postdoc
Six Tech transfer with MERS VLP vaccine
Experience on Clinical trials & licensing
Established Diagnostic Kit company before
Animal vaccine development, clinical trial, tech transfer and licensing

Kyung-Ho Lee

VSE Tech Manager

PhD on going
Swine vaccine development experience
Pet vaccine

Hye-Mi Lee, PhD

Immunologist

PhD in medical school
Proof of MOA, human vaccine development

Jun-Gyu Lee, PhD

Molecular Biologist

Virus engineering
VSE Tech

WADA MAI

VSE Tech Manager

Swine vaccine development experience
Pet vaccine development experience

Page updated

Google Sites

Report abuse